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Abstract
The use of transgenic plants as a production system for recombinant subunit vaccines has been considered safe and economical compared
to cell culture methods. We have exploited this approach to produce rinderpest virus hemagglutinin (H) protein in transgenic tobacco as a
model plant for testing the immunogenicity of plant-derived hemagglutinin protein. The transgenic nature of the plants was confirmed by
molecular analysis such as gene specific PCR and Southern hybridization using full-length H gene as a probe. The Mendelian pattern of
inheritance of the transgene has been demonstrated in T1 generation. The transgenic plants express the H protein of molecular weight 72
kDa. The plant derived H protein is antigenically authentic as revealed by reactivity with H-specific antibodies as well as convalescent sera.
The induction of immune response was tested in mice after intraperitoneal immunization with plant-derived H. High titers of antibodies were
induced which were H-specific and they neutralized the infectivity of rinderpest virus.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Transgenic plants offer an economic alternative to pro-
duce recombinant vaccine antigens (Mason and Arntzen,
1995). If the vaccine antigens are produced in the edible
parts of the plants, they can be directly consumed, providing
an easy way for mass immunization. Being produced in
plant system these antigens are safe, as there is no chance of
contamination of other pathogens. Storage of plant material
is easier compared to cell culture or fermentation-based
products, as plant-derived antigens do not need cold chain
maintenance. To date, several bacterial and viral antigens of
human pathogens (Haq et al., 1995; Huang et al., 2001;
Mason et al., 1996; McGarvey et al., 1995; Sandhu et al.,
2000; Thanavala et al., 1995) have been expressed in plant
systems. Although the vaccine trials in humans are limited
(Tacket et al., 1998, 2000), they have demonstrated the
induction of oral immune response, thus showing the fea-
sibility of developing plant-based edible oral vaccine. This
approach has also been utilized to develop transgenic plants
expressing vaccine antigens for animal diseases such as foot
and mouth disease and transmissible gastroenteritis (Tuboly
et al., 2000; Wigdorovitz et al., 1999a, 1999b).
Rinderpest is an acute, usually fatal, highly contagious
viral disease of cloven-hoofed animals, particularly cattle
and buffaloes. Although a live attenuated tissue culture-
adapted rinderpest vaccine exists (Plowright, 1962), it is not
robust. International eradication campaigns are thus suc-
cessful only in limiting the distribution of the disease. It is
still prevalent in many parts of Africa, the Middle East, and
South Asia (Barrett and Rossiter, 1999). The host cell mem-
brane-derived envelope of Rinderpest virus (RPV) contains
two virus-specific glycoproteins—hemagglutinin (H) and
fusion (F) protein. These glycoproteins are highly immuno-
genic and confer complete protection. Recombinant subunit
vaccines, vaccinia/capripox recombinant (Romero et al.,
1993, 1994; Yilma et al., 1988) or baculo recombinants,
have been produced (Bassiri et al., 1993; Naik et al., 1997).
Long-term immunity of recombinant vaccinia virus express-
ing rinderpest H has been tested in cattle (Ohishi et al.,
2000).
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Toward the aim of developing edible vaccine for rinder-
pest, tobacco was chosen as the model plant, since trans-
formation procedures are well standardized and the plant is
fast growing. The hemagglutinin gene of rinderpest virus
was introduced into tobacco by Agrobacterium-mediated
transformation or by direct particle bombardment. The in-
tegration of H gene into plant genomic DNA was estab-
lished and the expression as well as its antigenicity was
demonstrated. Finally, the immunogenicity of the plant-
expressed H protein was tested in a mouse model.
Results
Construction of binary vector
The recombinant binary vector pBI H was generated by
subcloning of full-length (1.9 kb) hemagglutinin gene from
RBH 3.4 into pBI121 in place of uid gene. Thus, the hem-
agglutinin gene is under the control of constitutively ex-
pressed CaMV 35S promoter and is terminated by NOS
terminator sequences (Fig. 1). The T-DNA region contains
the nptII gene in addition to the hemagglutinin gene, which
helps in selection of transformants on medium containing
kanamycin.
Genetic transformation of plants
Genetic transformation of tobacco with pBI H was
achieved by A. tumefaciens (EHA 105) or directly by par-
ticle bombardment as described under Materials and meth-
ods. The putative transformants selected on kanamycin
were tested for the presence of transgene by PCR. An
amplified product (700 bp) was observed when PCR was
performed using nptII-specific primers and genomic DNA
from transformed plants as template and this product was
absent when genomic DNA from nontransformed tobacco
plant was used (data not shown). Similarly in H-specific
PCR, the expected size (1.9 kb) product was obtained with
transformed plant DNA but was absent with nontrans-
formed plant (Fig. 2). Twenty-five independent lines gen-
erated by Agrobacterium-mediated transformation and 6
independent lines produced by particle bombardment
showed the presence of transgene. Further, the integration
of H in the genomic DNA of transformants was analyzed by
Southern hybridization. Genomic DNA when digested with
EcoRI showed the presence of a single band of size4.6 kb
when hybridized with the full-length H probe as expected.
Since the EcoRI site is present only once in T-DNA at the
Fig. 1. T-DNA region of the recombinant binary vector pBI H.
Fig. 2. Agarose gel electrophoresis showing amplification of H by PCR.
Lane M: lambda DNA/ HindIII digest; lane 1: genomic DNA from non-
transformed tobacco; lanes 2 and 3: genomic DNA from TRB1/2 and
TRB1/4; lanes 4–8: TRA1/6, TRA1/9, TRA1/10, TRA2/3, and TRA2/9,
respectively.
Fig. 3. Inheritance pattern of nptII gene in the second generation. (A) Plants
transformed by particle bombardment were used for the analysis of nptII
gene by PCR amplification. (B) Statistical analysis of results was per-
formed using chi-square test.
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extreme end (Fig. 1), a fragment carrying H gene will
always be equal to or more than 4.6 kb, which is the size of
the T-DNA, integrated into the plant genome. HindIII-di-
gested genomic DNA also showed the presence of a single
band, thus demonstrating single-copy insertion in most of
the lines (Fig. 3). Signals were absent in genomic DNA
digests of nontransformed tobacco plants. These positive
lines were allowed to self-pollinate and the seeds were
collected. The seeds from lines TRB1/2 and TRB1/4 were
germinated in Soilrite. Genomic DNA from approximately
35–40 T1 plants of each line was isolated from the leaves
and tested for the presence of transgene by nptII-specific
PCR. The ratio of the positive and negative plants with
respect to the transgene was subjected to statistical analysis.
The results (Fig. 4) clearly indicated a Mendelian segrega-
tion pattern.
Rinderpest virus hemagglutinin protein expression in
transgenic plants
Twenty-five independent lines were tested for the ex-
pression of the transgene by Western immunoblotting. The
expression of hemagglutinin protein was observed in these
lines when monospecific polyclonal antibody to H was
used. The percentage of H in total soluble protein was
estimated by a double antibody sandwich ELISA employing
recombinant secretory H and a monoclonal antibody to H
(data not shown) and maximum expression of H up to
0.75% was observed in one of the lines. One line (TRA1/10)
expressing the highest amount was used to authenticate the
nature of plant-derived hemagglutinin. Immunoblotting us-
ing different H-specific antibodies confirmed the authentic-
ity of plant-derived 72-kDa hemagglutinin protein (Figs.
5A–D). PCR-positive T1 plants were also analyzed for the
expression of hemagglutinin protein. Protein extracts were
made from the leaves and immunoblotted after electro-
phoretic separation using cross-reactive antibody to H (rab-
bit polyclonal anti-HN antibody), shown in Fig. 5E. Further,
the antigenicity of the plant-derived hemagglutinin (in both
T0 and T1 transgenic plants) protein was demonstrated by its
reactivity with serum from cattle recovered after rinderpest
Fig. 4. Southern hybridization of the transgenic tobacco plants. (M) end-labeled lambda DNA/HindIII digest. (A) Genomic DNA from putative transgenic
tobacco obtained by Agrobacterium-mediated transformation digested with HindIII. (B) Digested with EcoRI; lane 1: nontransformed tobacco; lanes 2–5:
TRA1/6, TRA1/9, TRA1/10, TRA2/3, and TRA2/9, respectively. (C) EcoRI digests of genomic DNA from transformants obtained by particle bombardment;
lane 1: nontransformed tobacco lanes 2 and 3: TRB1/2 and TRB1/4, respectively.
Fig. 5. Expression profile of plant-derived H in crude protein extract from
nontransformed tobacco plants (1) and from transgenic tobacco plant
TRA1/10 (2) by Western blotting. (A–C) Reactivity of plant-derived H to
(A) rabbit polyclonal monospecific antibody to H, (B) rabbit polyclonal
antibody to PPRV HN, (C) mouse monoclonal anotibody to H. (D) Con-
canavalin A blotting showing glycosylation status. (M) Protein molecular
weight marker. (E) Few lines of T1 tobacco plants expressing H.
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infection (Figs. 6A–C) and with serum from cattle immu-
nized with recombinant H (Figs. 6E and F). Cross-reactivity
of plant-derived hemagglutinin was tested by its reactivity
to antibody against the HN protein of the closely related
Peste des petits ruminants virus (PPRV) and serum from
convalescent sheep after infection by PPRV, as shown in
Figs. 6G and H, respectively.
Immunogenicity in mice
The immunogenicity of the plant-derived H was studied
in a mouse model. Adult female BALB/c mice were immu-
nized intraperitoneally with protein extracts from the trans-
formed (Group 1) and nontransformed tobacco (Group 2)
plants. The specificity of the serum collected from all five
mice of both groups, over a period of 70 days at weekly
intervals was analyzed in ELISA using recombinant secre-
tory H protein (Naik and Shaila, 1997) as antigen. H-
specific antibodies were remarkably higher in group 1 mice
immunized with transgenic tobacco plant extract than in
group 2 mice immunized with nontransformed tobacco
plant extract (Fig. 7). The specificity of these antibodies was
further confirmed by Western immunoblotting of protein
from virus-infected (RPV/PPRV Nig 75/1) or uninfected
Vero cell lysates as antigens. A 70-kDa protein correspond-
ing to H was detected only in infected cell lysates and no
signals were obtained in uninfected cell lysate when pooled
serum from mice immunized with transgenic tobacco ex-
pressing H was used as primary antibody (inset, Fig. 7),
Fig. 6. Antigenic authenticity of plant-derived H. (A–C) Reactivity of T0 and T1 tobacco-derived H and nontransformed tobacco to convalescent sera obtained
from three different buffaloes (Nos. 6, 63, 64), respectively. (D) Reactivity of T0 and T1 tobacco-derived H and nontransformed tobacco to normal cattle sera.
(E and F) Reactivity to cattle sera immunized with recombinant H. (G and H) Cross-reactivity of T0 and T1-derived H and nontransformed tobacco,
respectively, with convalescent sera from sheep recovered from PPRV infection and with antibody to PPRV-HN. Circle, triangle, and square represent
T0-derived H, T1-derived H and nontransformed tobacco, respectively.
Fig. 7. Specific antibody levels in mice after ip immunization with trans-
genic tobacco leaf extract. The antibody titer is defined as the log of the
reciprocal of the highest dilution of the serum which gave optical density
twice that given by serum from mice immunized with nontransformed
tobacco leaf extract. Inset: immunoreactivity of mice serum with antigens
from RPV-infected cell lysate (lane 1), PPRV-infected cell lysate (lane 2),
and uninfected cell lysate (lane 3).
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thus, demonstrating that the plant-derived H is eliciting a
specific antibody response.
The functional activity of these serum was demonstrated
by hemagglutination inhibition assay. PPRV has been
shown to possess hemagglutination activity (Ramachandran
et al., 1995). Serum from mice immunized intraperitoneally
with plant-derived H showed inhibition of hemagglutination
activity of PPRV, while this inhibition was not observed
when serum from mice immunized with nontransformed
tobacco plant extract was used (Fig. 7).
The virus neutralization ability of different serum sam-
ples was tested in vitro. A significant level of neutralizing
and cross-neutralizing antibody titers was detected (Table 1)
in the pooled serum derived from all five animals intraperi-
toneally immunized with transformed tobacco plant extract
over a period of 10 weeks postimmunization. However, no
neutralization activity against RPV or PPRV was detected
in serum from mice following intraperitoneal immunization
with nontransformed tobacco plant extracts, indicating pro-
tection against infection in vitro by immune serum. These
results demonstrate that plant-derived H protein is able to
induce functionally active anti-H antibodies in the mouse
model upon intraperitoneal immunization.
Discussion
As a first step toward generation of a hemagglutinin-
expressing transgenic fodder crop, which can be used as a
candidate edible vaccine for rinderpest, we developed trans-
genic tobacco plants expressing rinderpest virus hemagglu-
tinin protein. The antigenic nature of the plant-derived hem-
agglutinin protein based on its reactivity to H-specific
antibodies has been demonstrated. Further characterization
of the antibody response to plant-derived hemagglutinin in
a mouse model after intraperitoneal immunization shows
the induction of neutralizing antibodies in the experimental
model system.
The stability, solubility, folding, and biological activity
of a protein can be affected by glycosylation. Therefore
exposure of antigenic determinants of a glycoprotein de-
pend on its glycosylation status. N-linked glycan processing
differs in plants and mammals (Oxley and Bacic, 1995).
Factors, such as polypeptide folding, could influence the
availability of potential N-glycosylation sites in the ER. As
a consequence, when multiple N-glycosylation sites are
present in a protein sequence, some sites might be glyco-
sylated inefficiently, giving rise to various glycoforms,
whereas some others are not used at all (Crofts and De-
necke, 1998). Thus, the in vivo applications of pharmaceu-
tical recombinant glycoproteins produced in transgenic
plants strongly depend on their N-glycosylation patterns,
and N-glycosylation of a recombinant therapeutic glyco-
protein has to be determined in detail (Bardor et al., 1999).
RPV H protein has five potential N-glycosylation sites of
which four are glycosylated in infected cells and in mature
virions. We have shown the glycosylation of plant-derived
hemagglutinin protein by concanavalin A blotting. Al-
though the pattern of glycosylation and its extent has not
been determined, it is able to mount significant immune
response (Fig. 7), and more importantly, these antibodies
are able to neutralize virus infectivity in vitro (Table 1).
Particulate antigens are known to induce better immune
response in comparison to soluble antigens. Soluble anti-
gens need a very good delivery system that can carry the
antigen intact through the full repertoire of degrading con-
ditions of gastrointestinal tract such as acidic pH, proteases,
and bile acids. Lipid-based delivery systems, which include
ISCOMs, liposomes, and oil-based emulsions, are common.
Expression of antigens in plant cells provide bioencapsula-
tion of the antigen, thus enabling the antigen to maintain its
potency to induce immune response effectively (Kong et al.,
2001). There are few reports describing the immunogenic
nature of soluble proteins when expressed in plants and
delivered orally (Huang et al., 2001; Wigdorovitz et al.,
Table 1
Virus neutralization titers of pooled serum from five mice after
immunization with transgenic tobacco leaf extract until 9 weeks
postimmunization
Weeks postimmunization RPV PPRV
0 0 0
1 640 1280
2 160 1280
3 640 320
4 320 1280
5 640 80
6 160 80
7 320 40
8 320 80
9 320 80
Note. Virus neutralization and cross-neutralization titers are defined as
the reciprocal of the highest dilution of the serum which inhibited cyto-
pathic effect by 50%.
Table 2
Hemagglutination inhibition titers of pooled serum from five mice after
immunization with transgenic tobacco leaf extract (Group 1) and with
nontransformed tobacco leaf extract (Group 2) until 9 weeks
postimmunization
Weeks postimmunization Group 1
0 0
1 1280
2 1280
3 1280
4 1280
5 1280
6 1280
7 1280
8 1280
9 640
Note. Serum from Group 2 did not show any inhibition of hemaggluti-
nation. Hemagglutination inhibition titer is defined as the reciprocal of the
dilution, which showed 50% hemagglutination inhibition.
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1999a). In the report by Huang et al. (2001) induction of
neutralizing antibodies in mice upon intraperitoneal immu-
nization or oral immunization with measles virus hemag-
glutinin protein expressed in tobacco was demonstrated.
VP1 protein of foot and mouth disease virus expressed in
plants has been shown to induce protective immune re-
sponse in mice. This group has used different plants, ara-
bidopsis (Carrillo et al., 1998), alfalfa (Wigdorovitz et al.,
1999a), and potato (Carrillo et al., 2001), to express the
full-length VP1 and reported induction of specific immune
response through intraperitoneal or oral inoculation. More
recently, Dus Santos et al. (2002) expressed a small immu-
nogenic region, 135 to 165 aa, of VP1 in alfalfa plants and
showed the induction of significant immune response. In
contrast to these reports, the spike protein of swine-trans-
missible gastroenteritis virus (TGEV) expressed in potato
plants induced specific immune response when adminis-
tered either by ip or by oral route but failed to generate
neutralizing antibodies (Gomez et al., 2000). Earlier, Go-
mez et al. (1998) reported that S protein expressed in ara-
bidopsis is able to induce significant levels of neutralizing
antibodies when inoculated in mice intraperitoneally. The
authors have attributed this difference in induction of neu-
tralizing antibodies to the differences in posttranslational
modification of the glycoprotein in different plant species or
to the presence of other plant proteins. Different formula-
tions were used to immunize the mice, for arabidopsis-
derived protein and potato tuber extract, although the ex-
pression level in both plants is reported to be the same
(0.02–0.07%). Tuboly et al. (2000) have shown the immu-
nogenicity of S protein expressed in tobacco plants in pigs.
The protective ability of tobacco-derived S protein was
shown by virus neutralization test.
The antigenicity and immunogenicity of each antigen when
expressed in plants need to be tested, as the processing of
individual antigen may have different effects. Tobacco is the
most preferred model plant to express any foreign protein
because of its easy transformation and fast regeneration (Rich-
ter and Kipp, 1999). Similar to antigens such as LT-B (Haq et
al., 1995), hepatitis B surface antigen (Thanavala et al., 1995),
and measles virus hemagglutinin protein (Huang et al., 2001),
in the present study the rinderpest virus hemagglutinin gene
when expressed in tobacco plants maintained immunogenicity
in a mouse model. The results also demonstrate the generation
of neutralizing antibodies in mice upon intraperitoneal immu-
nization with crude extract from transgenic tobacco expressing
RPV H protein, thus indicating the potential of plant-derived
hemagglutinin protein as a vaccine candidate.
Materials and methods
Construction of expression vector (pBI H)
Hemagglutinin gene of rinderpest virus was subcloned in
binary vector pBI121. The uid gene of pBI121 is replaced
by H gene such that the gene will be under the control of
CaMV 35S promoter. pBI121 was digested with SmaI and
SacI to release the uid gene fragment. Full-length H gene
was obtained by EcoRI and BamHI digestion of RBH3.4
plasmid DNA, which contains the full-length DNA for H
derived from a cDNA library prepared using total mRNA
made in Vero cells infected with the vaccine strain of RPV
(RBOK) (kind gift from Dr. T. Barrett, Institute for Animal
Health, Pirbright, UK). Both the vector and the insert DNA
were end-polished using T4 DNA polymerase and ligated.
E. coli DH5 was used for transformation of the ligated
DNA. Transformants were selected on kanamycin-supple-
mented (50 mg/L) medium. Recombinants were checked for
the presence of H gene in correct orientation by XbaI digestion,
which should give a product of approximately 1.9 kb.
Mobilization of pBI H into Agrobacterium tumefaciens
(strain EHA 105)
The freeze–thaw method (Holsters et al., 1978) was used
for mobilizing pBI H into A. tumefaciens (EHA 105). Trans-
formants were selected on medium supplemented with
kanamycin (50 mg/L) and rifampicin (25 mg/L).
Genetic transformation of tobacco
Transformation of tobacco (Nicotiana tabacum var. Ha-
wana) was performed using the leaf disc method (Horsch et
al., 1986). In brief, small pieces of leaves were infected with
overnight-grown recombinant Agrobacterium harboring
pBI H for 5–10 min, blotted dry, and transferred to regen-
eration medium (MS1) containing MS (Murashige and
Skoog, 1962) salts and vitamins, 3% (w/v) sucrose, 2 mg/L
benzyl aminopurine (BAP), 0.5 mg/L naphthalene acetic
acid (NAA), and 0.8% agar. After 2 days of cocultivation
leaf discs were washed either with MS liquid or sterile
distilled water and transferred to selection medium contain-
ing appropriate antibiotics to select putative transformants.
Selection medium (MS2) contained MS1 supplemented
with 500 mg/L cefatoxime, 100 mg/L kanamycin. Root induc-
tion medium (MS3) contained MS salts and vitamins, 3%
(w/v) sucrose, 0.1 % indole acetic acid (IAA), 500 mg/L
cefatoxime, 100 mg/L kanamycin, and 0.8% phytagel. Rooted
T0 tobacco plantlets after hardening of roots in liquid MS
medium were transferred to Soilrite in small cups and were
maintained in the controlled environment of the growth cham-
ber for another 10 days before transfer to the green house. They
were allowed to grow to maturity and self-fertilize. Seeds were
collected and germinated in the soil and were tested for the
presence of transgene in T1 progeny.
Transformation of tobacco with H gene by particle
bombardment
Tobacco leaf discs were precultured onto regeneration
medium (MS1) for 2 days. Microprojectiles were prepared
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by coating recombinant pBI H plasmid DNA on 16-m
gold microbeads and the explants were bombarded using the
BioRad particle bombardment system as per manufacturer’s
instructions. After bombardment, explants were kept in the
dark for 2 days and then transferred to selection medium
(MS2).
Polymerase chain reaction (PCR) and Southern
hybridization
The presence of transgene was confirmed by PCR am-
plification of the nptII and H genes using specific primers.
Plant genomic DNA from putative transformants selected
on kanamycin-supplemented medium and nontransformed
tobacco plants for PCR analysis was isolated by the CTAB
(cetyltrimethylammonium bromide) method (Murray and
Thompson, 1980). The nptII primer sequences (5–3) GAG
GCT ATT CGG CTA TGA CTG and ATC GGG AGG
GGC GAT ACC GTA will amplify an internal fragment of
700 bp. The PCR was performed in a thermal cycler using
the following conditions: initial denaturation at 95°C for 3
min, followed by 35 cycles of denaturation at 95°C for 30 s,
annealing at 55°C for 45 s, synthesis at 72°C for 1 min and
final extension for 7 min at 72°C. The H primer sequences
(H1: 5-GGACTACAGTACCCCGCACGT-3 and H2: 3-
TGGTTAGTACTCCATACGCCGGTA-5) will amplify
the full-length (1.9 kb) H gene. The conditions used for the
PCR are as follows: initial denaturation at 95°C for 5 min,
followed by 35 cycles of denaturation at 95°C for 1 min,
annealing at 44°C for 1 min, synthesis at 72°C for 2 min,
and final extension for 10 min at 72°C. The PCR products
were analyzed by agarose gel electrophoresis.
For Southern hybridization 10 g of total genomic DNA
from transgenic plants and nontransformed control plants
was digested with EcoRI/HindIII. After agarose gel electro-
phoresis, DNA was transferred to a nylon membrane (Hy-
bond N, Amersham, UK) by capillary action overnight
(Sambrook et al., 1989). The 1.9-kb fragment of the H gene
was obtained by XbaI digestion of pBI H and radiolabeled
with [-32P]dCTP from Amersham (sp act 3000 Ci/mmol)
using a Random Priming labeling kit purchased from Am-
ersham as per manufacturer’s instructions. The radiolabeled
probe was denatured and used for hybridization after 2 h of
prehybridazion at 65°C in Church buffer (Church and Gil-
bert, 1984). Following hybridization at 65°C for 16 h, the
membrane was washed for 30 min each in 2 SSC  0.1%
SDS and 1 SSC  0.1% SDS at room temperature; 0.5
SSC 0.1% SDS and 0.1 SSC 0.1% SDS at 65°C. The
blot was exposed to phosphor imaging.
Western blotting
Leaf tissues (0.1 g) from transformed and nontrans-
formed tobacco plants were ground to a fine powder in
liquid nitrogen and resuspended in 500 L sample buffer
(100 mM Tris–HCI, pH 6.8, 4% SDS, 20% glycerol, 5%
-mercaptoethanol, and 0.2% bromphenol blue). The sam-
ples were boiled for 10 min, and the supernatants collected
by centrifugation at 13000 rpm for 15 min. The proteins
were subjected to electrophoresis on a 10% SDS–polyac-
rylamide gel and transferred to a nylon membrane. Bovine
gelatin in PBS (3% w/v) containing 0.1% Tween 20 was used
for blocking the membrane. The membrane was washed three
times with PBS containing 0.1% Tween 20 (PBST). Rabbit
polyclonal monospecific anti-H antibody, rabbit polyclonal
anti-HN antibody (Devireddy et al., 1998), and mouse mono-
clonal anti-H antibody (D2E4) (Renukaradhya et al., 2002)
were used as primary antibodies in individual blots and
incubated at 37°C for 1 h followed by three washes in
PBST. Incubation with AP-conjugated anti-rabbit or perox-
idase-conjugated anti-mouse antibodies at 37°C for 1 h was
performed and after three PBST washes the reaction was
developed with either BCIP/NBT or diaminobenzidine
(DAB). Con A blotting was done according to Kijimoto-
Ochiai et al. (1985).
ELISA
Total protein from leaves of transformed and nontrans-
formed tobacco plants was isolated using the method of
McGarvey et al. (1995). Twofold serial dilution of plant
extracts was performed in PBS and coated onto ELISA
plates at 4°C overnight. All further incubations were at
37°C for 1 h and the plate was washed three time with
PBST. Blocking was done in 0.2% fish gelatin in PBST
(v/v). Appropriate antibody dilutions were made for all
primary antibodies followed by peroxidase-conjugated anti-
cow, anti-mouse antibodies as secondary antibodies. The
plates were developed with o-phenylenediamine (OPD) tab-
lets purchased from Sigma for 10–15 min and read at 490
nm.
The amount of H in different transgenic lines was deter-
mined by using recombinant H protein in a secretory form
(SecH) (Naik and Shaila, 1997), to prepare a standard curve.
The level of H in SecH preparation was estimated by sep-
arating it on 10% SDS–polyacrylamide gels. The 68-kDa
band corresponding to H was analyzed by densitometric
scanning. Varying concentrations of H was used in ELISA
to make the standard curve (data not shown).
Immunogenicity in mice
Two groups, each containing five female BALB/c
(60–90 days old) mice were immunized intraperitoneally
with leaf extracts from transformed tobacco plants express-
ing H and nontransformed tobacco plants (10 g of H per
mouse) in complete Freund’s adjuvant for the first injection
followed by two boosters with half of the protein amount on
Days 7 and 14 in incomplete Freund’s adjuvant. Eleven
animals were bled retro-orbitally every week until 10 weeks
postimmunization and serum was collected and tested for
the presence of specific antibodies to H by ELISA using
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recombinant H as the antigen. Antibody titers are expressed
as the log of the reciprocal of the highest serum dilution that
gives OD readings twice the mean OD of serum from five
mice immunized with nontransformed tobacco plant extract.
Hemagglutination inhibition
Hemagglutination inhibition test to detect specific anti-
serum was done as described previously by Norrby (1962).
Virus neutralization test
In vitro virus neutralization (both homologous and cross-
neutralization) was performed using Vero cells grown in
MEM medium. Vaccine strain of RPV (RBOK strain) and
vaccine strain of PPRV Nig 75/1 were grown on Vero cells
and titrated employing the TCID50 method (Reed and
Muench, 1938). Pooled serum samples (for each bleed,
serum was pooled from all the five mice of the group) were
heat-inactivated at 56°C for 30 min followed by incubation
with 100 TCID50 of virus at 37°C for 1 h; 2 104 cells were
added to each well. The wells without the sera/virus served
as control. The plates were monitored for 5–7 days for
cytopathic effects (CPE) for RPV and 3–5 days for PPRV.
Virus neutralization titer was defined as the highest dilution
of the sera, which inhibited CPE by 50%.
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